Suppliers / Aino Co., Ltd.of North China Pharmaceutical Group

Aino Co., Ltd.of North China Pharmaceutical Group

China Updated 9 July 2026

Aino Co., Ltd.of North China Pharmaceutical Group is an API manufacturer based in China. It holds one valid CEP. Its most recent recorded inspection, by US FDA, closed on 17 January 2019 as VAI.

0
active US DMFs
1
valid CEPs
2
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
3 of 3 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 17 January 2019 VAI US FDA
  • 29 April 2016 VAI US FDA
  • 18 November 2011 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
China, China 3004090057
Shijiazhuang, China Not on file

What they file, and where

Molecule Regulators Docs
Ivermectin EDQM 1

Also appears on these molecule pages

Ivermectin API

Comparing suppliers?

Choose your molecules and target markets. Aino Co., Ltd.of North China Pharmaceutical Group comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 17 January 2019.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability